Sino Biopharmaceutical

Sino Biopharmaceutical is owned by Charoen Pokphand Group. Charoen Pokphand Group has a direct presence in 3 countries.

Charoen Pokphand Group has 6 subsidiaries including Ascend Money, Bellisio Foods and Charoen Pokphand Foods.

They are in:

• Food29%
• Industrial Conglomerates14%
• Other57%

View the org chart displaying its 21 main executives

Most searched biographies at Sino Biopharmaceutical

• Eric Tse, Executive Director and Chief Executive Officer
• Ping Tse, Senior Executive Vice Chairman of The Board
• Kwok Tung Li, Independent Non-Executive Director

Create your alert
to follow the executive moves at Sino Biopharmaceutical.

Charoen Pokphand Group has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Sino Biopharmaceutical

Social media about Sino Biopharmaceutical

• Sino Biopharmaceutical on Wikipedia, Google News & Yahoo Finance
• Sino Biopharmaceutical on LinkedIn, Twitter & YouTube

Call Sino Biopharmaceutical at +852 ...

View the org chart

Register to receive your alert

Report an error